Ebola Virus Disease News and Research

Latest Ebola Virus Disease News and Research

Research uncovers key process that enables Ebola virus to infect host cells

Researchers have identified a key process that enables the Ebola virus to infect host cells, providing a novel target for developing antiviral drugs.

6 Feb 2018

New TSRI study uncovers workings of first potential treatment for Marburg virus

With a mortality rate of up to 88 percent, Marburg virus can rip through a community in days. In 2005, an outbreak of Marburg virus struck a pediatric ward in the country of Angola. With no treatment available, doctors struggled to help as the virus killed 329 of 374 infected patients.

11 Jan 2018

Researchers find way to prevent Ebola infection from spreading

A single enzyme. That is all the researchers behind a new study need to manipulate to prevent the feared Ebola virus from spreading. Because with the enzyme they also take away the virus' ability to copy itself and thus produce more virus particles and more infection.

29 Dec 2017

Texas Biomed scientists develop new animal model that mimics key features of Zika infection

An alternative animal model that mimics key features of the Zika virus infection, including its lingering presence in bodily fluids, has been developed at Texas Biomedical Research Institute in San Antonio.

12 Dec 2017

Scientists identify biomarkers that predict risk of death in Ebola patients

Scientists have identified a set of biomarkers that indicate which patients infected with the Ebola virus are most at risk of dying from the disease.

17 Nov 2017

ACS recognizes contributions of five surgeons with Surgical Humanitarian and Volunteerism Awards

Last night, five surgeons received the 2017 American College of Surgeons/Pfizer Surgical Humanitarian Awards and Surgical Volunteerism Awards in recognition of their selfless efforts as volunteer surgeons who provide care to medically underserved patients abroad.

23 Oct 2017

Ebola vaccine that provides a year’s worth of protection developed

Liberia’s Ebola outbreak has yielded a successful trial of two vaccines against the deadly infection that could provide protection for up to a year and is also deemed to be safe.

12 Oct 2017

Penn study explains how acute viral infections can linger

Infections caused by viruses, such as respiratory syncytial virus, or RSV, measles, parainfluenza, and Ebola, are typically considered acute. These viruses cause disease quickly and live within a host for a limited time. But in some cases, the effects of the infection, and presence of the virus itself, can persist.

6 Oct 2017

Ebola vaccine found to be safe and effective for adults and children in Africa

Experts at St George's, University of London, have reported that an Ebola vaccine is safe for children as well as adults and produces an immune response.

6 Oct 2017

Northumbria researcher develops new, faster and safer way to diagnose Ebola virus

A new, faster and safer way of diagnosing the Ebola virus has been developed by an academic from Northumbria University, Newcastle.

28 Sep 2017

Scientists gain insight into how Ebola virus uses the body's defenses to speed up infection

Scientists from The University of Texas Medical Branch at Galveston have gained new insight into how the Ebola virus uses the body's natural defenses to speed the rate of infection and unleash its lethal disease, according to a new report in mBio.

26 Sep 2017

JWARG begins study to identify suspected severe infectious diseases in West Africa

The Joint West Africa Research Group began a study today designed to identify cases of suspected severe infectious disease at medical centers in West Africa. The study is being led by the U.S. Military HIV Research Program of the Walter Reed Army Institute of Research.

13 Sep 2017

Johns Hopkins researchers pinpoint how tiny protein could make deadly Ebola virus contagious

Two Johns Hopkins materials science graduate students and their professors played a key role in a multi-institution research project that pinpointed how a tiny protein seems to make the deadly Ebola virus particularly contagious.

22 Aug 2017

New research finds major disabilities in 80% of Ebola survivors one year after discharge

New research, conducted by Liverpool School of Tropical Medicine and the University of Liverpool, highlights the need for long-term rehabilitation of Ebola survivors after almost 80% of those interviewed were found to have major limitations in mobility, cognition, and vision.

21 Aug 2017

Stable vaccines using microscopic crystals from cypovirus

Scientists at Cell Guidance Systems, Cambridge University and Imperial College are exploiting microscopic crystals, made by a cypovirus, to produce stable vaccines for diseases that mostly affect the world's poorest people.

From Cell Guidance Systems 21 Aug 2017

Einstein researchers receive three NIH grants to protect against deadly viruses

The NIH has awarded Einstein researchers three grants totaling more than $12 million to protect against three deadly viruses--Ebola, Marburg and hantavirus.

11 Aug 2017

Georgia State receives high research funding to set record for sixth consecutive year

Georgia State University received $147 million in research funding in fiscal year 2017, setting a record for the sixth consecutive year.

4 Aug 2017

Ebola virus RNA can persist in semen of survivors two years after infection, researchers say

Ebola virus RNA can persist in the semen of survivors more than two years after the onset of infection researchers at the University of North Carolina at Chapel Hill have found.

2 Aug 2017

The Lancet's special issue examines Germany’s health system and emerging role as leader in global health

The two-paper Series is led by authors from the Berlin Institute of Technology and the Geneva Graduate Institute, and accompanied by a Comment from Germany’s Minister of Health, Hermann Gröhe.

6 Jul 2017

WHO declares Ebola outbreak in Democratic Republic of Congo now over

The World Health Organization (WHO) declared the end of the latest Ebola virus disease (EVD) outbreak in the Democratic Republic of Congo (DRC) last Saturday. This comes at 42 days after the last confirmed case of Ebola. The experts have said that two incubation period cycles of 21 days have passed with no new cases and thus it can be safely said that the outbreak has ended.

2 Jul 2017

Ebola Virus Disease News and Research

Latest Ebola Virus Disease News and Research

Research uncovers key process that enables Ebola virus to infect host cells

New TSRI study uncovers workings of first potential treatment for Marburg virus

Researchers find way to prevent Ebola infection from spreading

Texas Biomed scientists develop new animal model that mimics key features of Zika infection

Scientists identify biomarkers that predict risk of death in Ebola patients

ACS recognizes contributions of five surgeons with Surgical Humanitarian and Volunteerism Awards

Ebola vaccine that provides a year’s worth of protection developed

Penn study explains how acute viral infections can linger

Ebola vaccine found to be safe and effective for adults and children in Africa

Northumbria researcher develops new, faster and safer way to diagnose Ebola virus

Scientists gain insight into how Ebola virus uses the body's defenses to speed up infection

JWARG begins study to identify suspected severe infectious diseases in West Africa

Johns Hopkins researchers pinpoint how tiny protein could make deadly Ebola virus contagious

New research finds major disabilities in 80% of Ebola survivors one year after discharge

Stable vaccines using microscopic crystals from cypovirus

Einstein researchers receive three NIH grants to protect against deadly viruses

Georgia State receives high research funding to set record for sixth consecutive year

Ebola virus RNA can persist in semen of survivors two years after infection, researchers say

The Lancet's special issue examines Germany’s health system and emerging role as leader in global health

WHO declares Ebola outbreak in Democratic Republic of Congo now over

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Ebola Virus Disease News and Research

Latest Ebola Virus Disease News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in